Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Pathology|January 12, 2000
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissueH J Nielsen, U Hansen, I J Christensen, et al.
International Journal of Cancer|January 15, 1985
Endocrine sensitivity of the receptor-positive T61 human breast carcinoma serially grown in nude miceN Brünner, M Spang-Thomsen, H Skovgaard Poulsen, et al.
Cancer Research|March 15, 1989
Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude miceN Brünner, D Bronzert, L L Vindeløv, et al.
Scandinavian Journal of Gastroenterology|April 18, 2001
Increased levels of specific leukocyte- and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn diseaseH J Nielsen, T Mortensen, M Holten-Andersen, et al.
International Journal of Cancer|July 3, 1998
Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assayH De Witte, F Sweep, N Brünner, et al.
International Journal of Cancer|September 15, 1994
A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumorsH Solberg, J Rømer, N Brünner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 6, 1999
The urokinase plasminogen activator receptor in blood from healthy individuals and patients with cancerN Brünner, H J Nielsen, M Hamers, et al.
Biological Chemistry Hoppe-Seyler|May 1, 1995
Plasminogen activator inhibitor type 1 in cancer: therapeutic and prognostic implicationsH Pappot, H Gårdsvoll, J Rømer, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Effect of endocrine therapy on growth of T61 human breast cancer xenografts is directly correlated to a specific down-regulation of insulin-like growth factor II (IGF-II)N Brünner, D Yee, F G Kern, et al.
The American Journal of Pathology|February 1, 1989
Immunoreactive opioid peptides in human breast cancerL Scopsi, E Balslev, N Brünner, et al.
Pageof 15